| SRF'ing and SAP'ing–the role of MRTF proteins in cell migration D Gau, P Roy Journal of cell science 131 (19), jcs218222, 2018 | 83 | 2018 |
| Both actin and polyproline interactions of profilin-1 are required for migration, invasion and capillary morphogenesis of vascular endothelial cells Z Ding, D Gau, B Deasy, A Wells, P Roy Experimental cell research 315 (17), 2963-2973, 2009 | 75 | 2009 |
| Green fluorescent protein expression triggers proteome changes in breast cancer cells JVF Coumans, D Gau, A Poljak, V Wasinger, P Roy, P Moens Experimental cell research 320 (1), 33-45, 2014 | 48 | 2014 |
| Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by … JVF Coumans, D Gau, A Poljak, V Wasinger, P Roy, PDJ Moens Omics: a journal of integrative biology 18 (12), 778-791, 2014 | 40 | 2014 |
| BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility–A proteomics study DM Gau, JL Lesnock, BL Hood, R Bhargava, M Sun, K Darcy, S Luthra, ... Cell Cycle 14 (12), 1884-1892, 2015 | 39 | 2015 |
| Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis D Gau, W Veon, TL Capasso, R Bottcher, S Shroff, BL Roman, P Roy Angiogenesis 20, 663-672, 2017 | 34 | 2017 |
| Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells A Allen, D Gau, P Francoeur, J Sturm, Y Wang, R Martin, J Maranchie, ... Journal of Biological Chemistry 295 (46), 15636-15649, 2020 | 24 | 2020 |
| The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms M Joy, D Gau, N Castellucci, R Prywes, P Roy Journal of Biological Chemistry 292 (28), 11777-11791, 2017 | 24 | 2017 |
| Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1–actin interaction D Gau, T Lewis, L McDermott, P Wipf, D Koes, P Roy Journal of Biological Chemistry 293 (7), 2606-2616, 2018 | 22 | 2018 |
| Low PIP2 molar fractions induce nanometer size clustering in giant unilamellar vesicles IL Salvemini, DM Gau, J Reid, LA Bagatolli, A Macmillan, PDJ Moens Chemistry and physics of lipids 177, 51-63, 2014 | 19 | 2014 |
| Threonine 89 is an important residue of profilin-1 that is phosphorylatable by protein kinase A D Gau, W Veon, X Zeng, N Yates, SG Shroff, DR Koes, P Roy PloS one 11 (5), e0156313, 2016 | 17 | 2016 |
| Fluorescence Resonance Energy Transfer (FRET)-based Detection of Profilin–VASP Interaction D Gau, Z Ding, C Baty, P Roy Cellular and molecular bioengineering 4, 1-8, 2011 | 17 | 2011 |
| Mitochondria–actin cytoskeleton crosstalk in cell migration T Yadav, D Gau, P Roy Journal of cellular physiology 237 (5), 2387-2403, 2022 | 16 | 2022 |
| The VASP–profilin1 (Pfn1) interaction is critical for efficient cell migration and is regulated by cell–substrate adhesion in a PKA-dependent manner D Gau, W Veon, SG Shroff, P Roy Journal of Biological Chemistry 294 (17), 6972-6985, 2019 | 16 | 2019 |
| Single cell migration assay using human breast cancer MDA-MB-231 cell line DM Gau, P Roy Bio-protocol 10 (8), e3586-e3586, 2020 | 14 | 2020 |
| Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization D Gau, L Vignaud, A Allen, Z Guo, J Sahel, D Boone, D Koes, ... Journal of Biological Chemistry 295 (28), 9618-9629, 2020 | 13 | 2020 |
| Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells S Chakraborty, C Jiang, D Gau, M Oddo, Z Ding, L Vollmer, M Joy, ... British journal of cancer 119 (9), 1106-1117, 2018 | 13 | 2018 |
| The role of profilin-1 in cardiovascular diseases A Allen, D Gau, P Roy Journal of Cell Science 134 (9), jcs249060, 2021 | 10 | 2021 |
| Myocardin‐related transcription factor's interaction with serum‐response factor is critical for outgrowth initiation, progression, and metastatic colonization of breast cancer … D Gau, P Chawla, I Eder, P Roy FASEB BioAdvances 4 (8), 509, 2022 | 4 | 2022 |
| Inhibition of ocular neovascularization by novel anti-angiogenic compound D Gau, L Vignaud, P Francoeur, D Koes, X Guillonneau, P Roy Experimental eye research 213, 108861, 2021 | 4 | 2021 |
